Sign in Subscribe
United States. Securities and Exchange Commission

Xoma Corp. Files SEC Form 4 for May 22, 2015

Strategic Insights

— 1 min read

A U.S. Securities and Exchange Commission filing by Xoma Corp. was submitted on May 22, 2015, through Form 4, which is a document that discloses the ownership stakes of directors, officers, or shareholders with more than 10% equity in a company. The filing, with the SEC file number 0000791908-15-000065, revealed changes in the company's ownership structure and transactions involving its pharmaceutical preparations.

Key Takeaways:

  • The SEC filing was made by Xoma Corp. on May 22, 2015, under the SIC code 2834 for Pharmaceutical Preparations.
  • The filing was made by one person, though no further details on the individual are provided.
  • The contact information for Xoma Corp. includes a Berkeley, CA address and a phone number of 510-644-1170.
  • Form 4 is used for reporting changes in ownership and other events by insiders of a company.
  • Xoma Corp.'s SEC filing is available on the SEC website under the provided link.
  • Additional information about Form 4 is provided in the filing, detailing its purpose and structure.

Statistics:

  • One document was filed with Form 4.
  • The SEC file number for this filing is 0000791908-15-000065.
  • The contact information for Xoma Corp. is available through the SEC filing.
  • The SIC code for Xoma Corp. is 2834, Pharmaceutical Preparations.
  • The disclosure form is dated May 22, 2015.

Sources:

  • "U.S. Securities and Exchange Commission filing by Xoma Corp. (Form 4)" (May 22, 2015).
  • SEC Form 4 filing, file number 0000791908-15-000065.

Read more